Magnus Bäck
@ProfMagnusBack
Followers
168
Following
136
Media
1
Statuses
154
Joined November 2017
Simultaneously published with its presentation at #TCT2025 The IVUS-ACS Trial shows that IVUS-guided PCI markedly improves outcomes in ACS, especially for high-risk patients defined by the new TVF-ACS Risk-Score. A major step forward in precision interventional cardiology. 🔗
2
24
63
Breaking from #TCT2025 San Francisco 🔥 The IVUS-ACS Trial introduces the new TVF-ACS Risk-Score, that identifies ACS patients who benefit most from IVUS-guided PCI: 60% less TVF! 📖 Simultaneous publication in @ehjopen 👉 https://t.co/bolmt6uoQb
#OpenUpYourScience! @mmamas1973
1
3
8
Compelling news about multimorbidity in #Afib from the EHRA-PATHS consortium: published today https://t.co/Tt1ADzaEZ3 and https://t.co/F37T5Y3fBG with the accompanying Editorial https://t.co/6tAI6uE40M!
#OpenUpYourScience with @ehjopen #HorizonEU @ESC_Lavinia @ProfMagnusBack
academic.oup.com
This editorial refers to ‘Development of three-step holistic care pathways to detect and manage comorbidities in patients with atrial fibrillation: the Hor
0
2
3
Tackling multimorbidity in #AtrialFibrillation through holistic care & digital pathways: #EHRAPATHS and #AFFIRMO reshape AF management. 🔗 https://t.co/4otjA9M9jB 🔗 https://t.co/KKFkja78WT 🔗 https://t.co/L0j4Gja4mB
@ehjopen @SaDeRosa78 @ProfMagnusBack @EuropaceEiC
#EHJOpen
0
7
31
Routine screening for H. pylori infection during hospitalization 🏥 for acute #cvMI did not 🚫 significantly ↘️ bleeding events or ↗️ clinical outcomes, based on findings from the HELP-MI SWEDEHEART trial presented at #ESCCongress. Get the details: 🔗 https://t.co/rDexwHGi11
0
3
8
#ESCCongress – Étude HELP-MI Chez 18 466 patients CV, dépistage systématique de H. pylori ❌ pas de bénéfice significatif sur le risque d’hémorragie digestive 👉 Signal positif chez patients anémiques ✍️@A_Trimaille & @RakzaRedwane : https://t.co/Xq26aAycxw
0
3
2
Simultaneous publication during #ESCCongress Transcatheter Versus Surgical Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis : https://t.co/mFsriS3xl9
#EHJOpen
0
6
18
Don't miss the 2024 cardiovascular highlights from EHJ Open: a 5 min read in a 5 I's framework. https://t.co/x6hBvWdqcj
academic.oup.com
Intervention, Improved prevention, Imaging, Inflammation, and Innovation are highlights of some major insights from European Heart Journal Open 2024. Those
1
1
2
Higher standardized 10-year mortality rates after coronary stenting in women: still a long way to go! #OpenUpYourScience #WomensHealth @ESC_Lavinia @ProfMagnusBack @alaide_chief @WomenAs1 @WomenCardiology
https://t.co/QoPWkAEEt0
academic.oup.com
AbstractAims. Over time, clinical outcome after percutaneous coronary intervention (PCI) with contemporary drug-eluting stents (DES) has improved. While mo
0
4
6
Excited to publish our State of the Art Review on #multiomics & #pharmacotherapy in #aorticstenosis #AS with @ProfMagnusBack, @ESC_President @TomLuscher, & @AikawaElena in the European Heart Journal. Thanks for the invitation @ehj_ed #EHJ @ESC_Journal! https://t.co/cuXgdKSNLN
academic.oup.com
Abstract. Calcific aortic valve disease (CAVD) resulting in aortic stenosis (AS) is the most common form of valvular heart disease, affecting 2% of those o
0
6
20
Myocardial infarction and low ambient temperature: does presence or absence of stenoses make a difference? Read the editorial in @ehj_ed @ESC_Journals by @ProfMagnusBack and @Robodoc2013 from @KarolinskaUnsju
@karolinskainst on how to stay warm enough.
academic.oup.com
This editorial refers to ‘Low ambient temperature and incident myocardial infarction with or without obstructive coronary arteries: a Chinese nationwide st
0
1
3
What is the impact of Autonomic Reactivity to Mental #Stress on #Cardiovascular risk? #OpenUpYourScience with #EHJOpen! @ESC_Lavinia @ProfMagnusBack @SaDeRosa78 @DrMarthaGulati
academic.oup.com
AbstractAims. The mechanisms linking acute psychological stress to cardiovascular disease (CVD) mortality are incompletely understood. We studied the relat
1
5
13
#OpenUpYourScience with #EHJOpen!
Basal inferoseptal segment is highly susceptible to deformation in transthyretin-derived amyloid cardiomyopathy https://t.co/is61Oen1EE
#OpenUpYourScience with #EHJOpen! #WhyCMR #echofirst
@ESC_journals @SaDeRosa78 @ProfMagnusBack @giodisal @alessia_gimelli
1
1
3
More data link atrial fibrillation to embolic #stroke of undetermined source: full paper on #EHJOpen! https://t.co/pzYKFL2rH5
#OpenUpYourScience #ESUS
@ESC_Lavinia @ProfMagnusBack @SilCastelletti @mspartalis5
academic.oup.com
AbstractAims. Stroke is the most debilitating outcome of atrial fibrillation (AF). The use of implantable loop recorders increases the detection of AF epis
0
3
7
#CardiacArrest increases the mortality risk of #STEMI by 5-FOLD, but the events mostly occur within 10 months: read the whole story #OpenAcess on #EHJOpen! #OpenUpYourScience
@ESC_Lavinia @ProfMagnusBack @drmilicaa @ACVCPresident
https://t.co/Zmr2VWnsRG
0
5
20
Intra-individual variability in #Lipoproteina : the value of a repeat measure for reclassifying individuals at intermediate risk released at #ESCCongress and just published in #EHJOpen👉 https://t.co/Z07VFys93S
@ehjopen @TarekHarbMD @TZiogos @TLeucker
1
19
53
Please find attached our Editorial on the simultaneous publication on "Intra-individual #variability in lipoprotein(a) #LPA: the value of a repeat measure for reclassifying individuals at intermediate #risk" published today in #EHJOpen. @ehjopen Congratulations to the Authors
2
19
54
#ESCCongress2024 Our editorial for the very important study by Leucker et al. just presented during Lp(a) session: https://t.co/gDhO1Dl3vu
@maciejbanach @SABOURETCardio @ehjopen @ehj_ed @PoLACongress @ExpertLipid @Drlipid @SaDeRosa78 @pabeda1
0
3
10
Curious about the impact of Lp(a) on #cardiovascular risk? check the #ESCCongress session: https://t.co/4mShIeQ9wW simultaneous publication on #EHJOpen: https://t.co/vin7MQId43
#OpenUpYourScience
@ESC_Journals @SaDeRosa78 @ProfMagnusBack @TLeucker @maciejbanach @SABOURETCardio
academic.oup.com
AbstractAims. Lipoprotein(a) [Lp(a)] levels are predominantly genetically determined and repeat measurements are generally considered unlikely to be clinic
0
7
27
Published in @eBioMedicine today : https://t.co/UOO1Ya7Y9j
Read the latest news from @Inserm @Univ_Lorraine @CHRU_de_Nancy on @MedscapeFrance to learn about novel results on #vascular stiffness and cardiovascular risk
1
2
12